Trial intelligence / Profile preview

PRP for Lumbar Facet Osteoarthritis

NCT04522674Phase 1Completed

Sponsor
University of Colorado Denver
Start
Feb 2021
Primary completion
Apr 2022
Modality
Adoptive Cell Transfer
Countries
1
01

Overview

Phase 1, open-label, single-arm trial of autologous platelet-rich plasma in osteoarthritis (OA), sponsored by University of Colorado Denver. Primary endpoints: Visual Analog Scale Pain Score at 3 months and PROMIS Survey for Low Back Pain Function at 3 months. Started Feb 2021; status: completed.

02

Drugs

autologous platelet-rich plasma
03

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on NCT04522674.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04522674.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call